000 01296 a2200337 4500
005 20250517172331.0
264 0 _c20190424
008 201904s 0 0 eng d
022 _a1029-2330
024 7 _a10.1080/1061186X.2017.1374389
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVarghese, Nila Mary
245 0 0 _aNanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
_h[electronic resource]
260 _bJournal of drug targeting
_c03 2018
300 _a195-207 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAcquired Immunodeficiency Syndrome
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aAnti-Retroviral Agents
_xadministration & dosage
650 0 4 _aBlood-Brain Barrier
_xmetabolism
650 0 4 _aBrain
_xmetabolism
650 0 4 _aDrug Carriers
_xadministration & dosage
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aNanoparticles
_xadministration & dosage
700 1 _aSenthil, Venkatachalam
700 1 _aSaxena, Shailendra K
773 0 _tJournal of drug targeting
_gvol. 26
_gno. 3
_gp. 195-207
856 4 0 _uhttps://doi.org/10.1080/1061186X.2017.1374389
_zAvailable from publisher's website
999 _c27523130
_d27523130